Radiation Dose to Patients from Radiopharmaceuticals

A Task Group within ICRP Committee 2 and 3 is continuously working to improve absorbed dose estimates to patients investigated with radiopharmaceuticals. The work deals with reviews of the literatu ...

[1]  H. Griffiths,et al.  Radiation Dose to Patients from Radiopharmaceuticals. ICRP Publication 53 , 1988 .

[2]  C Hoeschen,et al.  Minimising activity and dose with enhanced image quality by radiopharmaceutical administrations. , 2010, Radiation protection dosimetry.

[3]  S. Mattsson,et al.  Biokinetics and radiation dosimetry for patients undergoing a glycerol tri[1-14C]oleate fat malabsorption breath test. , 2003, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[4]  H. Honda,et al.  O-(2-[18F]fluoroethyl)-l-tyrosine (18F-FET) uptake in mouse thymoma cells, and its biodistribution in mice and human volunteers , 2006, Acta radiologica.

[5]  David G. Cadena,et al.  Limits for Intakes of Radionuclides by Workers. ICRP Publication 30, Part 3 , 1983 .

[6]  H. McClure,et al.  Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rhesus monkeys , 1990, Antimicrobial Agents and Chemotherapy.

[7]  H. Minn,et al.  Kinetics of [(11)C]choline uptake in prostate cancer: a PET study. , 2004, European journal of nuclear medicine and molecular imaging.

[8]  J C Mazziotta,et al.  The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  Felix M Mottaghy,et al.  Improving binding potential analysis in [11C]raclopride PET studies using cluster analysis. , 2004, Medical physics.

[10]  D. Mankoff,et al.  18F-Fluorothymidine radiation dosimetry in human PET imaging studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  H. Herzog,et al.  Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-l-tyrosine , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  G. Mannaerts,et al.  Alpha-oxidation of 3-methyl-substituted fatty acids and its thiamine dependence. , 2003, European journal of biochemistry.

[13]  G. Firnau,et al.  Estimation of the radiation dose in man due to 6-[18F]fluoro-L-dopa. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  M Schwaiger,et al.  Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  M. Schwaiger,et al.  Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  P. Franken,et al.  Intra-individual comparison of 3(R)-BMIPP and 3(S)-BMIPP isomers in humans. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  R. Taillefer,et al.  Acute thromboscintigraphy with (99m)Tc-apcitide: results of the phase 3 multicenter clinical trial comparing 99mTc-apcitide scintigraphy with contrast venography for imaging acute DVT. Multicenter Trial Investigators. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  A. Giussani,et al.  Compartmental model of 18F-choline , 2010, Medical Imaging.

[19]  S. Reske,et al.  [18F]3'-deoxy-3'-fluorothymidine-PET in NHL patients: whole-body biodistribution and imaging of lymphoma manifestations--a pilot study. , 2004, Cancer biotherapy & radiopharmaceuticals.

[20]  K. Hiraga,et al.  High‐resolution electron microscopy of technegas and pertechnegas , 1996, Nuclear medicine communications.

[21]  P. Shreve,et al.  Imaging of the pancreas and related diseases with PET carbon-11-acetate. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  P. Franken,et al.  Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  M. Goodman,et al.  New radioiodinated methyl-branched fatty acids for cardiac studies , 2004, European Journal of Nuclear Medicine.

[24]  A. Luxen,et al.  Production of 6-[18F]fluoro-L-dopa and its metabolism in vivo--a critical review. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[25]  K. F. Eckerman,et al.  Specific absorbed fractions of energy at various ages from internal photon sources: 6, Newborn , 1987 .

[26]  R. Coleman,et al.  Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  Jack Valentin,et al.  Radiation dose to patients from radiopharmaceuticals , 1991 .

[28]  W M Burch,et al.  Technegas - a new ventilation agent for lung scanning , 1986, Nuclear medicine communications.

[29]  S. Reske,et al.  Assessment of Regional Myocardial Uptake and Metabolism of ω-(p-123I-Phenyl) Pentadecanoic Acid with Serial Single-Photon Emission Tomography , 1982, Nuklearmedizin.

[30]  P. Cumming,et al.  Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects. , 1986, Life sciences.

[31]  H D Humes,et al.  Carbon-11-acetate PET imaging in renal disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  M E Phelps,et al.  Compartment model for measuring myocardial oxygen consumption using [1-11C]acetate. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  C Flexner,et al.  Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials. , 1994, The Journal of infectious diseases.

[34]  G. V. von Schulthess,et al.  Fluorocholine PET/CT in patients with prostate cancer: initial experience. , 2005, Radiology.

[35]  Jeroen J. Bax,et al.  Evaluation of heart-to-organ ratios of 123I-BMIPP and the dimethyl-substituted 123I-DMIPP fatty acid analogue in humans. , 1997, Nuclear medicine communications.

[36]  Ming-fang Wang,et al.  Pharmacokinetics and radiation dosimetry estimation of O-(2-[18F]fluoroethyl)-L-tyrosine as oncologic PET tracer. , 2003, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[37]  R. Leggett,et al.  A proposed blood circulation model for Reference Man. , 1995, Health physics.

[38]  H. Minn,et al.  Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography , 2000, European Journal of Nuclear Medicine.

[39]  G. Blake,et al.  Quantitative studies of bone using 18F-fluoride and 99mTc-methylene diphosphonate: evaluation of renal and whole-blood kinetics , 2001, Nuclear medicine communications.

[40]  R. Sievert,et al.  Book Reviews : Recommendations of the International Commission on Radiological Protection (as amended 1959 and revised 1962). I.C.R.P. Publication 6. 70 pp. PERGAMON PRESS. Oxford, London and New York, 1964. £1 5s. 0d. [TB/54] , 1964 .

[41]  I. Sesterhenn,et al.  Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  Y. Yonekura,et al.  [A Phase 1 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid (123I-BMIPP)]. , 1991, Kaku igaku. The Japanese journal of nuclear medicine.

[43]  Z. Bhujwalla,et al.  Choline phospholipid metabolism: A target in cancer cells? , 2003, Journal of cellular biochemistry.

[44]  T. Isawa,et al.  Technegas for inhalation lung imaging , 1991, Nuclear medicine communications.

[45]  K Wienhard,et al.  F-Dopa as an amino acid tracer to detect brain tumors. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[46]  M. Cantone.  ICRP publication 106 : radiation dose to patients from radiopharmaceuticals : a third amendment to ICRP 53 , 2009 .

[47]  Jae Seung Kim,et al.  [18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  F. Knapp,et al.  Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives , 1995, European Journal of Nuclear Medicine.

[49]  Michael G. Stabin,et al.  SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0* , 2010, The Journal of Nuclear Medicine.

[50]  T. Ishikawa,et al.  Bladder wall radiation dose in humans from fluorine-18-FDOPA. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[51]  D. Taylor.  Protection of the patient in radionuclide investigations: A report prepared for the International Commission on Radiological Protection. ICRP Publication 17. Pergamon Press, Oxford, 1971, 84 pp. £2. , 1972 .

[52]  S. Reske.  123I-phenylpentadecanoic acid as a tracer of cardiac free fatty acid metabolism. Experimental and clinical results. , 1985, European heart journal.

[53]  K. Dutschka,et al.  Biochemical concept and synthesis of a radioiodinated phenylfatty acid for in vivo metabolic studies of the myocardium , 1980, European Journal of Nuclear Medicine.

[54]  J. Lieberman,et al.  Characterization of in vivo Pharmacokinetic Properties of the Dopamine D1 Receptor Agonist DAR-0100A in Nonhuman Primates Using PET with [11C] NNC112 and [11C] Raclopride , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[55]  R. Rosell,et al.  Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. , 2002, Biochemical and biophysical research communications.

[56]  Mark Muzi,et al.  Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[57]  J. Valentin.  Basic anatomical and physiological data for use in radiological protection: reference values , 2002, Annals of the ICRP.

[58]  K Morita,et al.  The role of fatty acids in cardiac imaging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[59]  A. Luxen,et al.  The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans. , 1990, Life sciences.

[60]  D. Taylor.  Generic models for radionuclide dosimetry: 11C-, 18F- or 75Se-labelled amino acids. , 2000, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[61]  M. Ribeiro,et al.  Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[62]  A. Luxen,et al.  PET radiopharmaceuticals in Europe: Current use and data relevant for the formulation of summaries of product characteristics (SPCs) , 1995, European Journal of Nuclear Medicine.

[63]  M. Goodman,et al.  Structurally modified fatty acids: Clinical potential as tracers of metabolism , 2004, European Journal of Nuclear Medicine.

[64]  A. Shields,et al.  Radiosyntheses of labeled beta-pseudothymidine ([C-11]- and [H-3]methyl) and its biodistribution and metabolism in normal and tumored mice. , 1995, Nuclear medicine and biology.

[65]  H. Minn,et al.  Biodistribution and radiation dosimetry of [11C]choline: a comparison between rat and human data , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[66]  A. Bossuyt,et al.  Effect of oral glucose loading on the biodistribution of BMIPP in normal volunteers. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[67]  G. Blake,et al.  Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate. , 2001, Seminars in nuclear medicine.

[68]  Jack Valentin,et al.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. , 2007, Annals of the ICRP.

[69]  Ws Snyder,et al.  MIRD Pamphlet #11: S, Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs , 1975 .

[70]  K F Eckerman,et al.  Electron absorbed fractions and dose conversion factors for marrow and bone by skeletal regions. , 1994, Health physics.

[71]  M. Laruelle,et al.  [11C]NNC 112 Selectivity for Dopamine D1 and Serotonin 5-HT2A Receptors: A PET Study in Healthy Human Subjects , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.